Replies to post #17026 on Health Discovery Corp (HDVY)

[Zenos Arrow]

>>>Have you ever seen any CEO in any stock hang in there like McGovern?<<<

I think HDC’s resilience has been their steadfast belief in its patentability of their patents, along with its effectiveness in the clinical diagnostics sector. This company came to rise during the mapping of the genome, and the subsequent burgeoning sub-sector of proteomics. HDC’s technology found patterns in a seemingly infinite amount of data. And as the OVA 1 test asserted, found a “protein fingerprint” for ovarian and potentially other cancers.

Then, after an unbelievable opportunity to partner with the two largest diagnostic companies; Quest Dx (clinical) and Abbot (manufacturing) to develop lab testing (Lab Developed Test – LDTs) … it all went downhill. Not because of HDC’s technology, but their incompetence in providing data analysis back to these partners.

It did get worse. Rivaled only by Kramer’s impulsive acceptance of free Lattes in Seinfeld’s Hot Coffee Lawsuit episode, HDC settled with Aspira Labs and Neogenomics for (what amounted to) “free coffee.” BTW, both labs are reputable competitors in the esoteric lab testing sector.

So, it would be a fitting end if our company finally cashes in on their patents. In the end, fairness. The Long Arch of Justice theory. I know, we're not there yet, but this time, I don’t think even HDC can stand in its way.